Cargando…

Data Mining of Atherosclerotic Plaque Transcriptomes Predicts STAT1-Dependent Inflammatory Signal Integration in Vascular Disease

Atherosclerotic plaque development involves multiple extra- and intra-cellular signals engaging cells from the immune system and from the vasculature. Pro-inflammatory pathways activated by interferon gamma (IFNγ) and toll-like receptor 4 (TLR4) ligands are profoundly involved in plaque formation an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sikorski, Krzysztof, Wesoly, Joanna, Bluyssen, Hans A. R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159852/ https://www.ncbi.nlm.nih.gov/pubmed/25196434 http://dx.doi.org/10.3390/ijms150814313

Ejemplares similares

STAT1 as a central mediator of IFNγ and TLR4 signal integration in vascular dysfunction
por: Sikorski, Krzysztof, et al.
Publicado: (2012)

STAT1-Dependent Signal Integration between IFNγ and TLR4 in Vascular Cells Reflect Pro-Atherogenic Responses in Human Atherosclerosis
por: Chmielewski, Stefan, et al.
Publicado: (2014)

Identification of STAT1 and STAT3 Specific Inhibitors Using Comparative Virtual Screening and Docking Validation
por: Szelag, Malgorzata, et al.
Publicado: (2015)

SINBAD, structural, experimental and clinical characterization of STAT inhibitors and their potential applications
por: Plens-Gałąska, Martyna, et al.
Publicado: (2022)

Signal Integration of IFN-I and IFN-II With TLR4 Involves Sequential Recruitment of STAT1-Complexes and NFκB to Enhance Pro-inflammatory Transcription
por: Piaszyk-Borychowska, Anna, et al.
Publicado: (2019)

Targeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular disease
por: Szelag, Malgorzata, et al.
Publicado: (2016)

The epigenetic landscape of clear-cell renal cell carcinoma
por: Kluzek, Katarzyna, et al.
Publicado: (2015)

Potential Approaches and Recent Advances in Biomarker Discovery in Clear-Cell Renal Cell Carcinoma
por: Majer, Weronika, et al.
Publicado: (2015)

Thyroid cancers of follicular origin in a genomic light: in-depth overview of common and unique molecular marker candidates
por: Pstrąg, Natalia, et al.
Publicado: (2018)

A Positive Feedback Amplifier Circuit That Regulates Interferon (IFN)-Stimulated Gene Expression and Controls Type I and Type II IFN Responses
por: Michalska, Agata, et al.
Publicado: (2018)

STAT2/IRF9 directs a prolonged ISGF3-like transcriptional response and antiviral activity in the absence of STAT1
por: Blaszczyk, Katarzyna, et al.
Publicado: (2015)

STAT2-directed pathogen responses
por: Bluyssen, Hans
Publicado: (2015)

Microanatomy of the Human Atherosclerotic Plaque by Single-Cell Transcriptomics
por: Depuydt, Marie A.C., et al.
Publicado: (2020)

Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy
por: Eskandarian Boroujeni, Mahdi, et al.
Publicado: (2022)

Direct Inhibition of IRF-Dependent Transcriptional Regulatory Mechanisms Associated With Disease
por: Antonczyk, Aleksandra, et al.
Publicado: (2019)

Inflammatory Cytokines and Atherosclerotic Plaque Progression. Therapeutic Implications
por: Sterpetti, Antonio V
Publicado: (2020)

Genome-Wide Inhibition of Pro-atherogenic Gene Expression by Multi-STAT Targeting Compounds as a Novel Treatment Strategy of CVDs
por: Plens-Galaska, Martyna, et al.
Publicado: (2018)

Signature transcriptome analysis of stage specific atherosclerotic plaques of patients
por: Verma, Sonia, et al.
Publicado: (2022)

Decoding the transcriptome of calcified atherosclerotic plaque at single-cell resolution
por: Alsaigh, Tom, et al.
Publicado: (2022)

The Time-Dependent Role of Bisphosphonates on Atherosclerotic Plaque Calcification
por: Bakhshian Nik, Amirala, et al.
Publicado: (2022)

Angiogenesis in the atherosclerotic plaque
por: Camaré, Caroline, et al.
Publicado: (2017)

FUT11 as a potential biomarker of clear cell renal cell carcinoma progression based on meta-analysis of gene expression data
por: Zodro, Elżbieta, et al.
Publicado: (2013)

Increased vascular permeability is a surrogate marker of atherosclerotic plaque instability
por: Phinikaridou, Alkystis, et al.
Publicado: (2015)

TCF7 is highly expressed in immune cells on the atherosclerotic plaques, and regulating inflammatory signaling via NFκB/AKT/STAT1 signaling
por: Ma, Zhongnan, et al.
Publicado: (2022)

Inflammatory Factors Driving Atherosclerotic Plaque Progression New Insights
por: Song, Boce, et al.
Publicado: (2022)

Transcriptomic and Proteomic Profiling of Human Stable and Unstable Carotid Atherosclerotic Plaques
por: Bao, Mei-hua, et al.
Publicado: (2021)

Inflammatory Mediators in Atherosclerotic Vascular Remodeling
por: Evans, Bryce R., et al.
Publicado: (2022)

Time-dependent recruitment of GAF, ISGF3 and IRF1 complexes shapes IFNα and IFNγ-activated transcriptional responses and explains mechanistic and functional overlap
por: Sekrecka, Agata, et al.
Publicado: (2023)

Imaging the carotid atherosclerotic plaque
por: Neumann, Sandra, et al.
Publicado: (2019)

Capsanthin Inhibits Atherosclerotic Plaque Formation and Vascular Inflammation in ApoE(−/−) Mice
por: Kim, Sungmin, et al.
Publicado: (2022)

Atherosclerotic Plaque Biomarkers: Beyond the Horizon of the Vulnerable Plaque
por: W. van Lammeren, Guus, et al.
Publicado: (2011)

Aldehyde dehydrogenase 2 inhibits inflammatory response and regulates atherosclerotic plaque
por: Pan, Chang, et al.
Publicado: (2016)

Impact of Alirocumab on Release Markers of Atherosclerotic Plaque Vulnerability in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque
por: Kosowski, Michał, et al.
Publicado: (2022)

TRAIL-expressing T cells induce apoptosis of vascular smooth muscle cells in the atherosclerotic plaque
por: Sato, Kayoko, et al.
Publicado: (2006)

Loss of soluble guanylyl cyclase in platelets contributes to atherosclerotic plaque formation and vascular inflammation
por: Mauersberger, Carina, et al.
Publicado: (2022)

Osteopontin and osteoprotegerin in atherosclerotic plaque – are they significant markers of plaque vulnerability?
por: Strobescu-Ciobanu, Cristina, et al.
Publicado: (2020)

The Elusive Origin of Atherosclerotic Plaque Calcification
por: Canet-Soulas, Emmanuelle, et al.
Publicado: (2021)

Clinical Molecular Imaging for Atherosclerotic Plaque
por: Kondakov, Anton, et al.
Publicado: (2021)

Cellular crosstalk in atherosclerotic plaque microenvironment
por: Mahdinia, Elmira, et al.
Publicado: (2023)

Residual risks and evolving atherosclerotic plaques
por: Noothi, Sunil K., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_uc8b3jih5i15obo75osevjen0m